Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2004 Jun;80(3):174–182. doi: 10.1136/sti.2002.004101

Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges

P Mayaud 1, D Mabey 1
PMCID: PMC1744836  PMID: 15169997

Abstract

Sexually transmitted infections (STIs) constitute a huge health and economic burden for developing countries: 75–85% of the estimated 340 million annual new cases of curable STIs occur in these countries, and STIs account for 17% economic losses because of ill health. The importance of STIs has been more widely recognised since the advent of the HIV/AIDS epidemic, and there is good evidence that the control of STIs can reduce HIV transmission. The main interventions which could reduce the incidence and prevalence of STIs include primary prevention (information, education and communication campaigns, condom promotion, use of safe microbicides, and vaccines), screening and case finding among vulnerable groups (for example, pregnant women), STI case management using the syndromic approach, targeted interventions for populations at high risk (for example, sex workers), and in some circumstances (targeted) periodic mass treatment. The challenge is not just to develop new interventions, but to identify barriers to the implementation of existing tools, and to devise strategies for ensuring that effective STI control programmes are implemented in the future.

Full Text

The Full Text of this article is available as a PDF (277.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alary Michel, Mukenge-Tshibaka Léonard, Bernier France, Geraldo Nassirou, Lowndes Catherine M., Meda Honoré, Gnintoungbè Cyriaque A. B., Anagonou Séverin, Joly Jean R. Decline in the prevalence of HIV and sexually transmitted diseases among female sex workers in Cotonou, Benin, 1993-1999. AIDS. 2002 Feb 15;16(3):463–470. doi: 10.1097/00002030-200202150-00019. [DOI] [PubMed] [Google Scholar]
  2. Aral S. O., Holmes K. K., Padian N. S., Cates W., Jr Overview: individual and population approaches to the epidemiology and prevention of sexually transmitted diseases and human immunodeficiency virus infection. J Infect Dis. 1996 Oct;174 (Suppl 2):S127–S133. doi: 10.1093/infdis/174.supplement_2.s127. [DOI] [PubMed] [Google Scholar]
  3. Celentano D. D., Nelson K. E., Lyles C. M., Beyrer C., Eiumtrakul S., Go V. F., Kuntolbutra S., Khamboonruang C. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS. 1998 Mar 26;12(5):F29–F36. doi: 10.1097/00002030-199805000-00004. [DOI] [PubMed] [Google Scholar]
  4. Connolly A. M., Wilkinson D., Harrison A., Lurie M., Karim S. S. Inadequate treatment for sexually transmitted diseases in the South African private health sector. Int J STD AIDS. 1999 May;10(5):324–327. doi: 10.1258/0956462991914195. [DOI] [PubMed] [Google Scholar]
  5. Corbett Elizabeth L., Steketee Richard W., ter Kuile Feiko O., Latif Ahmed S., Kamali Anatoli, Hayes Richard J. HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet. 2002 Jun 22;359(9324):2177–2187. doi: 10.1016/S0140-6736(02)09095-5. [DOI] [PubMed] [Google Scholar]
  6. Crabbé F., Carsauw H., Buvé A., Laga M., Tchupo J. P., Trebucq A. Why do men with urethritis in Cameroon prefer to seek care in the informal health sector? Genitourin Med. 1996 Jun;72(3):220–222. doi: 10.1136/sti.72.3.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dallabetta G. A., Gerbase A. C., Holmes K. K. Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect. 1998 Jun;74 (Suppl 1):S1–11. [PubMed] [Google Scholar]
  8. Elwy A. Rani, Hart Graham J., Hawkes Sarah, Petticrew Mark. Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men: a systematic review. Arch Intern Med. 2002 Sep 9;162(16):1818–1830. doi: 10.1001/archinte.162.16.1818. [DOI] [PubMed] [Google Scholar]
  9. Garcia P. J., Gotuzzo E., Hughes J. P., Holmes K. K. Syndromic management of STDs in pharmacies: evaluation and randomised intervention trial. Sex Transm Infect. 1998 Jun;74 (Suppl 1):S153–S158. [PubMed] [Google Scholar]
  10. Gerbase A. C., Rowley J. T., Mertens T. E. Global epidemiology of sexually transmitted diseases. Lancet. 1998;351 (Suppl 3):2–4. doi: 10.1016/s0140-6736(98)90001-0. [DOI] [PubMed] [Google Scholar]
  11. Ghys Peter D., Diallo Mamadou O., Ettiègne-Traoré Virginie, Kalé Kouamé, Tawil Oussama, Caraël Michel, Traoré Moussa, Mah-Bi Guessan, De Cock Kevin M., Wiktor Stefan Z. Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Côte d'Ivoire, 1991-1998. AIDS. 2002 Jan 25;16(2):251–258. doi: 10.1097/00002030-200201250-00015. [DOI] [PubMed] [Google Scholar]
  12. Gray R. H., Wawer M. J., Brookmeyer R., Sewankambo N. K., Serwadda D., Wabwire-Mangen F., Lutalo T., Li X., vanCott T., Quinn T. C. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001 Apr 14;357(9263):1149–1153. doi: 10.1016/S0140-6736(00)04331-2. [DOI] [PubMed] [Google Scholar]
  13. Green M., Hoffman I. F., Brathwaite A., Wedderburn M., Figueroa P., Behets F., Dallabetta G., Hoyo C., Cohen M. S. Improving sexually transmitted disease management in the private sector: the Jamaica experience. AIDS. 1998;12 (Suppl 2):S67–S72. [PubMed] [Google Scholar]
  14. Grosskurth H., Gray R., Hayes R., Mabey D., Wawer M. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet. 2000 Jun 3;355(9219):1981–1987. doi: 10.1016/S0140-6736(00)02336-9. [DOI] [PubMed] [Google Scholar]
  15. Grosskurth H., Mayaud P., Mosha F., Todd J., Senkoro K., Newell J., Gabone R., Changalucha J., West B., Hayes R. Asymptomatic gonorrhoea and chlamydial infection in rural Tanzanian men. BMJ. 1996 Feb 3;312(7026):277–280. doi: 10.1136/bmj.312.7026.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995 Aug 26;346(8974):530–536. doi: 10.1016/s0140-6736(95)91380-7. [DOI] [PubMed] [Google Scholar]
  17. Hawkes S., Morison L., Foster S., Gausia K., Chakraborty J., Peeling R. W., Mabey D. Reproductive-tract infections in women in low-income, low-prevalence situations: assessment of syndromic management in Matlab, Bangladesh. Lancet. 1999 Nov 20;354(9192):1776–1781. doi: 10.1016/s0140-6736(99)02463-0. [DOI] [PubMed] [Google Scholar]
  18. Hawkes Sarah, Mabey David, Mayaud Phillippe. Partner notification for the control of sexually transmitted infections. BMJ. 2003 Sep 20;327(7416):633–634. doi: 10.1136/bmj.327.7416.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Holmes K. K., Johnson D. W., Kvale P. A., Halverson C. W., Keys T. F., Martin D. H. Impact of a gonorrhea control program, including selective mass treatment, in female sex workers. J Infect Dis. 1996 Oct;174 (Suppl 2):S230–S239. doi: 10.1093/infdis/174.supplement_2.s230. [DOI] [PubMed] [Google Scholar]
  20. Hopkins D. R. Control of yaws and other endemic treponematoses: implementation of vertical and/or integrated programs. Rev Infect Dis. 1985 May-Jun;7 (Suppl 2):S338–S342. doi: 10.1093/clinids/7-supplement_2.s338. [DOI] [PubMed] [Google Scholar]
  21. Imrie J., Stephenson J. M., Cowan F. M., Wanigaratne S., Billington A. J., Copas A. J., French L., French P. D., Johnson A. M., Behavioural Intervention in Gay Men Project Study Group A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ. 2001 Jun 16;322(7300):1451–1456. doi: 10.1136/bmj.322.7300.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jacobs B., Kambugu F. S. K., Whitworth J. A. G., Ochwo M., Pool R., Lwanga A., Tifft S., Lule J., Cutler J. R. Social marketing of pre-packaged treatment for men with urethral discharge (Clear Seven) in Uganda. Int J STD AIDS. 2003 Mar;14(3):216–221. doi: 10.1258/095646203762869250. [DOI] [PubMed] [Google Scholar]
  23. Kamali A., Quigley M., Nakiyingi J., Kinsman J., Kengeya-Kayondo J., Gopal R., Ojwiya A., Hughes P., Carpenter L. M., Whitworth J. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet. 2003 Feb 22;361(9358):645–652. doi: 10.1016/s0140-6736(03)12598-6. [DOI] [PubMed] [Google Scholar]
  24. Kaul Rupert, Kimani Joshua, Nagelkerke Nico J., Fonck Karoline, Keli Florence, MacDonald Kelly S., Ronald Allan R., Plummer Francis A., Bwayo Job J., Ngugi Elizabeth N. Reduced HIV risk-taking and low HIV incidence after enrollment and risk-reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya. J Acquir Immune Defic Syndr. 2002 May 1;30(1):69–72. doi: 10.1097/00042560-200205010-00009. [DOI] [PubMed] [Google Scholar]
  25. Khamboonruang C., Beyrer C., Natpratan C., Keawvichit R., Wongworapat K., Eiumtrakul S., Celentano D. D., Nelson K. E. Human immunodeficiency virus infection and self-treatment for sexually transmitted diseases among northern Thai men. Sex Transm Dis. 1996 Jul-Aug;23(4):264–269. doi: 10.1097/00007435-199607000-00003. [DOI] [PubMed] [Google Scholar]
  26. Korenromp E. L., Van Vliet C., Grosskurth H., Gavyole A., Van der Ploeg C. P., Fransen L., Hayes R. J., Habbema J. D. Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS. 2000 Mar 31;14(5):573–593. doi: 10.1097/00002030-200003310-00013. [DOI] [PubMed] [Google Scholar]
  27. Koutsky Laura A., Ault Kevin A., Wheeler Cosette M., Brown Darron R., Barr Eliav, Alvarez Frances B., Chiacchierini Lisa M., Jansen Kathrin U., Proof of Principle Study Investigators A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002 Nov 21;347(21):1645–1651. doi: 10.1056/NEJMoa020586. [DOI] [PubMed] [Google Scholar]
  28. Laga M., Alary M., Nzila N., Manoka A. T., Tuliza M., Behets F., Goeman J., St Louis M., Piot P. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet. 1994 Jul 23;344(8917):246–248. doi: 10.1016/s0140-6736(94)93005-8. [DOI] [PubMed] [Google Scholar]
  29. Leiva A., Shaw M., Paine K., Manneh K., McAdam K., Mayaud P. Management of sexually transmitted diseases in urban pharmacies in The Gambia. Int J STD AIDS. 2001 Jul;12(7):444–452. doi: 10.1258/0956462011923471. [DOI] [PubMed] [Google Scholar]
  30. Mabey D., Peeling R. W., Perkins M. D. Rapid and simple point of care diagnostics for STIs. Sex Transm Infect. 2001 Dec;77(6):397–398. doi: 10.1136/sti.77.6.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mathews C., Coetzee N., Zwarenstein M., Lombard C., Guttmacher S., Oxman A., Schmid G. Strategies for partner notification for sexually transmitted diseases. Cochrane Database Syst Rev. 2001;(4):CD002843–CD002843. doi: 10.1002/14651858.CD002843. [DOI] [PubMed] [Google Scholar]
  32. Mauck C., Rosenberg Z., Van Damme L., International Working Group on Microbicides Recommendations for the clinical development of topical microbicides: an update. AIDS. 2001 May 4;15(7):857–868. doi: 10.1097/00002030-200105040-00006. [DOI] [PubMed] [Google Scholar]
  33. Mayaud P., Mabey D. C. Managing sexually transmitted diseases in the tropics: is a laboratory really needed? Trop Doct. 2000 Jan;30(1):42–46. doi: 10.1177/004947550003000122. [DOI] [PubMed] [Google Scholar]
  34. Mayaud P., McCormick D. Interventions against sexually transmitted infections (STI) to prevent HIV infection. Br Med Bull. 2001;58:129–153. doi: 10.1093/bmb/58.1.129. [DOI] [PubMed] [Google Scholar]
  35. Mayaud P., Mosha F., Todd J., Balira R., Mgara J., West B., Rusizoka M., Mwijarubi E., Gabone R., Gavyole A. Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial. AIDS. 1997 Dec;11(15):1873–1880. doi: 10.1097/00002030-199715000-00013. [DOI] [PubMed] [Google Scholar]
  36. Mayaud P., Uledi E., Cornelissen J., ka-Gina G., Todd J., Rwakatare M., West B., Kopwe L., Manoko D., Grosskurth H. Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania. Sex Transm Infect. 1998 Jun;74 (Suppl 1):S139–S146. [PubMed] [Google Scholar]
  37. Merson M. H., Dayton J. M., O'Reilly K. Effectiveness of HIV prevention interventions in developing countries. AIDS. 2000 Sep;14 (Suppl 2):S68–S84. [PubMed] [Google Scholar]
  38. Nelson K. E., Celentano D. D., Eiumtrakol S., Hoover D. R., Beyrer C., Suprasert S., Kuntolbutra S., Khamboonruang C. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med. 1996 Aug 1;335(5):297–303. doi: 10.1056/NEJM199608013350501. [DOI] [PubMed] [Google Scholar]
  39. O'Farrell N. Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes. Sex Transm Infect. 1999 Dec;75(6):377–384. doi: 10.1136/sti.75.6.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. O'Reilly K. R., Piot P. International perspectives on individual and community approaches to the prevention of sexually transmitted disease and human immunodeficiency virus infection. J Infect Dis. 1996 Oct;174 (Suppl 2):S214–S222. doi: 10.1093/infdis/174.supplement_2.s214. [DOI] [PubMed] [Google Scholar]
  41. Parker R. G., Easton D., Klein C. H. Structural barriers and facilitators in HIV prevention: a review of international research. AIDS. 2000 Jun;14 (Suppl 1):S22–S32. doi: 10.1097/00002030-200006001-00004. [DOI] [PubMed] [Google Scholar]
  42. Peterman T. A., Lin L. S., Newman D. R., Kamb M. L., Bolan G., Zenilman J., Douglas J. M., Jr, Rogers J., Malotte C. K. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis. 2000 Sep;27(8):446–451. doi: 10.1097/00007435-200009000-00004. [DOI] [PubMed] [Google Scholar]
  43. Plummer F. A., Nagelkerke N. J., Moses S., Ndinya-Achola J. O., Bwayo J., Ngugi E. The importance of core groups in the epidemiology and control of HIV-1 infection. AIDS. 1991;5 (Suppl 1):S169–S176. [PubMed] [Google Scholar]
  44. Rekart Michael L., Patrick David M., Chakraborty Bubli, Maginley Juanita J. L., Jones H. D., Bajdik Chris D., Pourbohloul Babak, Brunham Robert C. Targeted mass treatment for syphilis with oral azithromycin. Lancet. 2003 Jan 25;361(9354):313–314. doi: 10.1016/s0140-6736(03)12335-5. [DOI] [PubMed] [Google Scholar]
  45. Reynolds Steven J., Risbud Arun R., Shepherd Mary E., Zenilman Jonathan M., Brookmeyer Ronald S., Paranjape Ramesh S., Divekar Anand D., Gangakhedkar Raman R., Ghate Manisha V., Bollinger Robert C. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis. 2003 Apr 23;187(10):1513–1521. doi: 10.1086/368357. [DOI] [PubMed] [Google Scholar]
  46. Stanberry Lawrence R., Spruance Spotswood L., Cunningham Anthony L., Bernstein David I., Mindel Adrian, Sacks Stephen, Tyring Stephen, Aoki Fred Y., Slaoui Moncef, Denis Martine. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med. 2002 Nov 21;347(21):1652–1661. doi: 10.1056/NEJMoa011915. [DOI] [PubMed] [Google Scholar]
  47. Stephenson J. M., Imrie J., Sutton S. R. Rigorous trials of sexual behaviour interventions in STD/HIV prevention: what can we learn from them? AIDS. 2000;14 (Suppl 3):S115–S124. [PubMed] [Google Scholar]
  48. Sumartojo E., Carey J. W., Doll L. S., Gayle H. Targeted and general population interventions for HIV prevention: towards a comprehensive approach. AIDS. 1997 Aug;11(10):1201–1209. doi: 10.1097/00002030-199710000-00002. [DOI] [PubMed] [Google Scholar]
  49. Terris-Prestholt F., Watson-Jones D., Mugeye K., Kumaranayake L., Ndeki L., Weiss H., Changalucha J., Todd J., Lisekie F., Gumodoka B. Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect. 2003 Oct;79(5):375–381. doi: 10.1136/sti.79.5.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Thomas T., Choudhri S., Kariuki C., Moses S. Identifying cervical infection among pregnant women in Nairobi, Kenya: limitations of risk assessment and symptom-based approaches. Genitourin Med. 1996 Oct;72(5):334–338. doi: 10.1136/sti.72.5.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Tuladhar S. M., Mills S., Acharya S., Pradhan M., Pollock J., Dallabetta G. The role of pharmacists in HIV/STD prevention: evaluation of an STD syndromic management intervention in Nepal. AIDS. 1998;12 (Suppl 2):S81–S87. [PubMed] [Google Scholar]
  52. Van Damme Lut, Ramjee Gita, Alary Michel, Vuylsteke Bea, Chandeying Verapol, Rees Helen, Sirivongrangson Pachara, Mukenge-Tshibaka Léonard, Ettiègne-Traoré Virginie, Uaheowitchai Charn. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002 Sep 28;360(9338):971–977. doi: 10.1016/s0140-6736(02)11079-8. [DOI] [PubMed] [Google Scholar]
  53. Vickerman P., Watts C., Alary M., Mabey D., Peeling R. W. Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women. Sex Transm Infect. 2003 Oct;79(5):363–367. doi: 10.1136/sti.79.5.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wald Anna, Corey Lawrence. How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis? J Infect Dis. 2003 May 15;187(10):1509–1512. doi: 10.1086/374976. [DOI] [PubMed] [Google Scholar]
  55. Wald Anna, Link Katherine. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2001 Dec 14;185(1):45–52. doi: 10.1086/338231. [DOI] [PubMed] [Google Scholar]
  56. Zimet G. D., Mays R. M., Fortenberry J. D. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis. 2000 Jan;27(1):49–52. doi: 10.1097/00007435-200001000-00010. [DOI] [PubMed] [Google Scholar]
  57. del Mar Pujades Rodríguez María, Obasi Angela, Mosha Frank, Todd Jim, Brown David, Changalucha John, Mabey David, Ross David, Grosskurth Heiner, Hayes Richard. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS. 2002 Feb 15;16(3):451–462. doi: 10.1097/00002030-200202150-00018. [DOI] [PubMed] [Google Scholar]
  58. van der Geest S. Self-care and the informal sale of drugs in south Cameroon. Soc Sci Med. 1987;25(3):293–305. doi: 10.1016/0277-9536(87)90232-2. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES